Treatment and medicine | Dose | Time |
---|---|---|
Induction and re-induction therapy | ||
CODPL | ||
DEX or Pred | 10 mg/m2(maximum:10 mg) or 60 mg/m2(maximum:60 mg) | d1–28(reduction in 1 week) |
VCR | 1.5 mg/m2(maximum:2 mg) | d1, 8, 15, 22 |
CTX | 1 g/m2 | d1 |
DNR or IDR | 40-60 mg/m2 or 8-10 mg/m2 | d1, 8 |
L-asp | 10,000 U/m2 | d15, 17, 19, 21, 23, 25, 27, 29, 31, 33 |
Consolidation therapy | ||
HDMTX×2 | ||
HDMTX | 2.5–3.5 g/m2 | d1, 22 |
VCR | 1.5 mg/m2 | d1, 8, 15, 22 |
DNR or IDR | 40-60 mg/m2 or 8-10 mg/m2 | d8, 10 |
HDMTX | ||
HDMTX | 2.5–3.5 g/m2 | d1 |
VCR | 1.5 mg/m2 | d1 |
HDAra-C | ||
HDAra-C | 2 g/m2 | d1–3 |
DNR or IDR | 40-60 mg/m2 or 8-10 mg/m2 | d2–3 |
IFO | ||
IFO | 1 g/m2 | d1–5 |
VP-16 | 100 mg/m2 | d3–5 |
VCR | 1.5 mg/m2 | d1 |
Maintenance therapy | ||
6-MP | 50 mg/m2 | once a day |
MTX | 20 mg/m2 | once a week |